Decade-Long hunt for answers: is a lifesaving drug safe for unborn babies?
NCT ID NCT05477953
Summary
This study aims to understand the risks of taking the Chagas disease medicine nifurtimox during pregnancy. Researchers will follow about 50 women who took the drug while pregnant, collecting data on birth defects, pregnancy outcomes, and the health of their babies for up to a year. The goal is to gather safety information by comparing these results to what is seen in the general population, as current warnings are based on animal studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHAGAS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Many Locations
Multiple Locations, West Virginia, 26505, United States
-
Many Locations
Multiple Locations, Argentina
-
Many Locations
Multiple Locations, Bolivia
-
Many Locations
Multiple Locations, Chile
-
Many Locations
Multiple Locations, Colombia
-
Many Locations
Multiple Locations, El Salvador
-
Many Locations
Multiple Locations, Germany
-
Many Locations
Multiple Locations, Guatemala
-
Many Locations
Multiple Locations, Mexico
-
Many Locations
Multiple Locations, Spain
-
Many Locations
Multiple Locations, Uruguay
-
Many locations
Multiple Locations, Honduras
Conditions
Explore the condition pages connected to this study.